APC
GILD icon

Aspire Private Capital’s Gilead Sciences GILD Stock Holding History

Aspire Private Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-675
Closed -$56.6K – 346
2024
Q3 		$56.6K Buy
675
+21
+3% +$1.6K 0.01% 224
2024
Q2 		$44.8K Buy
654
+133
+26% +$8.88K 0.01% 243
2024
Q1 		$38.2K Buy
521
+37
+8% +$2.85K 0.01% 257
2023
Q4 		$39.3K Sell
484
-70
-13% -$5.45K 0.01% 248
2023
Q3 		$41.5K Sell
554
-7
-1% -$538 0.01% 229
2023
Q2 		$43.2K Sell
561
-136
-20% -$10.8K 0.01% 219
2023
Q1 		$57.8K Sell
697
-124
-15% -$10.3K 0.02% 191
2022
Q4 		$70.5K Sell
821
-52
-6% -$4.12K 0.03% 166
2022
Q3 		$54K Sell
873
-77
-8% -$4.86K 0.02% 186
2022
Q2 		$59K Sell
950
-24
-2% -$1.49K 0.02% 185
2022
Q1 		$58K Sell
974
-365
-27% -$23.3K 0.02% 196
2021
Q4 		$97K Sell
1,339
-228
-15% -$15.7K 0.03% 168
2021
Q3 		$109K Sell
1,567
-263
-14% -$18.5K 0.04% 157
2021
Q2 		$126K Sell
1,830
-2,783
-60% -$186K 0.04% 161
2021
Q1 		$298K Sell
4,613
-3,818
-45% -$246K 0.1% 112
2020
Q4 		$491K Buy
8,431
+1,582
+23% +$95.5K 0.19% 75
2020
Q3 		$433K Buy
6,849
+4,377
+177% +$304K 0.18% 77
2020
Q2 		$190K Sell
2,472
-4,922
-67% -$377K 0.09% 95
2020
Q1 		$553K Buy
7,394
+570
+8% +$39.4K 0.3% 54
2019
Q4 		$443K Sell
6,824
-156
-2% -$10.2K 0.19% 78
2019
Q3 		$442K Buy
6,980
+6,799
+3,756% +$444K 0.21% 74
2019
Q2 		$12K Buy
181
+53
+41% +$3.49K 0.01% 253
2019
Q1 		$8K Hold
128
– – ﹤0.01% 330
2018
Q4 		$8K Buy
+128
New +$8.95K ﹤0.01% 315

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aspire Private Capital's GILD Position: Q4 2024 in Review

Aspire Private Capital sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 675 shares — an estimated $56.6K sold.

Aspire Private Capital first reported a position in GILD in Q4 2018 and held it in 24 quarters. The position peaked at $553K in Q1 2020. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Aspire Private Capital reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • Aspire Private Capital sold 675 Gilead Sciences shares in Q4 2024, an estimated $56.6K.
  • Aspire Private Capital first reported a position in Gilead Sciences in Q4 2018 and held it in 24 quarters.
  • Aspire Private Capital's Gilead Sciences position peaked at $553K in Q1 2020.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.